Status:
COMPLETED
Transcutaneous Measurement of Jaundice in the Newborn
Lead Sponsor:
Norwegian University of Science and Technology
Conditions:
Hyperbilirubinemia, Neonatal
Jaundice, Neonatal
Eligibility:
All Genders
1-28 years
Brief Summary
Prospective comparison of measurement of bilirubin in jaundiced newborns by a transcutaneous device (bilirubinometer) and laboratory analysis of blood samples. We hypothesise that correlation of the ...
Detailed Description
Whenever a blood sample is drawn for measurement of bilirubin in a newborn, a transcutaneous measurement of skin yellow color will be made. Such measurements will also be included in all infants when ...
Eligibility Criteria
Inclusion
- Newborn infant admitted to normal newborn nursery
Exclusion
- Informed consent not obtained
Key Trial Info
Start Date :
July 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2013
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT01169740
Start Date
July 1 2010
End Date
October 1 2013
Last Update
March 28 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Olavs University Hospital
Trondheim, Norway, N-7006